+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Transgenic expression of kallikrein prevents from diabetic cardiomyopathy by inhibition of ICAM-1 induction and infiltration



Transgenic expression of kallikrein prevents from diabetic cardiomyopathy by inhibition of ICAM-1 induction and infiltration



European Heart Journal 23(Abstract Suppl.): 205, August-September




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 035974129

Download citation: RISBibTeXText


Related references

Transgenic expression of kallikrein prevents left ventricular dysfunction and inhibits endothelial induction of ICAM-1 and intramyocardial LFA-1/Mac-1+ infiltration in streptozotocin-induced diabetic cardiopathy in rats. Circulation 104(17 Suppl.): II 198, October 23, 2001

Transgenic expression of human kallikrein prevents sarcoplasmic reticular calcium ion transport dysfunction in diabetic rat heart. Hypertension 36(4): 655, 2000

Transgenic expression of human kallikrein prevents haemodynamic alterations and decline in sarcoplasmic reticulum calcium pump activity in diabetic rats. European Heart Journal 21(Abstract Suppl.): 3, August-September, 2000

Transgenic Expression of miR-133a in the Diabetic Akita Heart Prevents Cardiac Remodeling and Cardiomyopathy. Frontiers in Cardiovascular Medicine 6: 45, 2019

Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene. Faseb Journal 18(7): 828-835, 2004

Inhibition of JNK by novel curcumin analog C66 prevents diabetic cardiomyopathy with a preservation of cardiac metallothionein expression. American Journal of Physiology. Endocrinology and Metabolism 306(11): E1239-E1247, 2014

Transgenic expression of human kallikrein prevents altered left ventricular function, the decline in sarcoplasmic reticulum calcium pump activity and the rise in cardiac collagen content in diabetic rats. Circulation 102(18 Suppl.): II 267, October 31, 2000

Inhibition of submandibular and lacrimal gland infiltration in nonobese diabetic mice by transgenic expression of soluble TNF-receptor p55. Journal of Clinical Investigation 98(4): 954-961, 1996

Ultraviolet radiation effects on human keratinocyte icam 1 expression uv induced inhibition of cytokine induced icam 1 mrna expression is transient differentially restored for ifn gamma versus tnf alpha and followed by icam 1 induction via tnf alpha like pathway. Journal of Investigative Dermatology 98(6): 923-928, 1992

Transgenic activation of the kallikrein-kinin system prevents streptozotocin-diabetic hearts from cardiac fibrosis and left ventricular dysfunction. European Heart Journal 22(Abstract Suppl.): 54, 2001

Transgenic activation of the kallikrein-kinin system inhibits intramyocardial inflammation, endothelial dysfunction and oxidative stress in experimental diabetic cardiomyopathy. Faseb Journal 19(14): 2057-2059, 2005

Prevention of sarcoplasmic reticular Ca transport dysfunction in diabetic heart with transgenic human kallikrein expression is not due to altered SERCA2 and phospholamban expression. Naunyn-Schmiedeberg's Archives of Pharmacology 362(4-5 Suppl.): R29, 2000

Puerarin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of inflammation. Journal of Asian Natural Products Research 2018: 1-18, 2018

Inhibition of ICAM-1 expression by antisense oligonucleotides prevents ischemia/reperfusion injury, reduces MHCII expression and enables immediate graft function after renal transplantation. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 655A, Sept, 1997

Curcumin prevents reperfusion injury following ischemic stroke in rats via inhibition of NF‑κB, ICAM-1, MMP-9 and caspase-3 expression. Molecular Medicine Reports 16(4): 4710-4720, 2017